Agarwal Arjun — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Agarwal Arjun has filed 4 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $2.29M.

Profile

Agarwal Arjun

Agarwal Arjun is a finance executive who, according to the most recent SEC filing dated 2026-03-17, serves as Senior Vice President, Finance at Oruka Therapeutics, Inc. This role places him as the senior finance leader responsible for the company's financial planning, reporting, and related governance functions. Beyond the information contained in the SEC filing, public sources do not provide a detailed career history, education, or personal background for this individual. There is no publicly disclosed net worth, and no widely available biographical profile confirming other positions, awards, or affiliations. The available SEC reference does not indicate death; however, there is no independent confirmation of this individual's full biographical details outside the filing. Name variations suggest the person could also be listed as Arjun Agarwal in other records. Based on SEC filings, there is limited public information beyond his current role.

RoleSenior Vice President, Finance
Notability20/100

Board memberships

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-13ORKAOruka Therapeutics, Inc.S — Open-market sale [10b5-1]300$85.63$26K
2026-07-13ORKAOruka Therapeutics, Inc.S — Open-market sale [10b5-1]5.7K$84.90$480K
2026-07-13ORKAOruka Therapeutics, Inc.S — Open-market sale [10b5-1]3.7K$84.26$315K
2026-07-13ORKAOruka Therapeutics, Inc.S — Open-market sale [10b5-1]300$83.07$25K
2026-07-13ORKAOruka Therapeutics, Inc.M — Option exercise [10b5-1]1.5K$34.39$50K
2026-07-13ORKAOruka Therapeutics, Inc.M — Option exercise [10b5-1]8.5K$12.50$107K
2026-06-22ORKAOruka Therapeutics, Inc.S — Open-market sale699$82.14$57K
2026-06-22ORKAOruka Therapeutics, Inc.S — Open-market sale888$80.01$71K
2026-06-15ORKAOruka Therapeutics, Inc.S — Open-market sale395$69.69$28K
2026-06-15ORKAOruka Therapeutics, Inc.S — Open-market sale3.3K$70.34$229K
2026-06-15ORKAOruka Therapeutics, Inc.S — Open-market sale4.3K$69.85$303K
2026-06-15ORKAOruka Therapeutics, Inc.S — Open-market sale1.9K$68.34$127K
2026-06-15ORKAOruka Therapeutics, Inc.M — Option exercise1.5K$34.39$50K
2026-06-15ORKAOruka Therapeutics, Inc.M — Option exercise8.0K$12.50$100K
2026-05-18ORKAOruka Therapeutics, Inc.S — Open-market sale700$61.16$43K
2026-05-18ORKAOruka Therapeutics, Inc.S — Open-market sale800$60.34$48K
2026-05-18ORKAOruka Therapeutics, Inc.S — Open-market sale4.6K$59.19$272K
2026-05-18ORKAOruka Therapeutics, Inc.S — Open-market sale4.2K$58.34$244K
2026-05-18ORKAOruka Therapeutics, Inc.M — Option exercise5.8K$34.39$201K
2026-05-18ORKAOruka Therapeutics, Inc.M — Option exercise2.0K$12.50$25K

Companies — Last 90 Days

Frequently Asked Questions

Who is Agarwal Arjun?

Agarwal Arjun is a finance executive who, according to the most recent SEC filing dated 2026-03-17, serves as Senior Vice President, Finance at Oruka Therapeutics, Inc. This role places him as the senior finance leader responsible for the company's financial planning, reporting, and related governance functions. Beyond the information contained in the SEC filing, public sources…

How many SEC Form 4 filings has Agarwal Arjun submitted recently?

4 primary Form 4 filings in the last 90 days, covering 1 company.

Has Agarwal Arjun been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 15 open-market sales ($2.29M) across all tracked filings.

Where can I see all of Agarwal Arjun's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Agarwal Arjun profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.